rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2002-4-2
|
pubmed:abstractText |
Propofol is a potential vector of infection, because it contains no preservative. Thus, the manufacturer's specific recommendations for preparing injections or infusions go beyond the guidelines commonly used in our operating rooms for preparing other iv drugs. The purpose of the present study was to determine whether in the daily routine of an operating theatre a modified propofol handling technique can prevent contamination as effectively as do the manufacturer's handling recommendations.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0832-610X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
347-52
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11927472-Anesthetics, Intravenous,
pubmed-meshheading:11927472-Disinfection,
pubmed-meshheading:11927472-Drug Compounding,
pubmed-meshheading:11927472-Drug Contamination,
pubmed-meshheading:11927472-Drug Packaging,
pubmed-meshheading:11927472-Fungi,
pubmed-meshheading:11927472-Humans,
pubmed-meshheading:11927472-Infusions, Intravenous,
pubmed-meshheading:11927472-Laminectomy,
pubmed-meshheading:11927472-Neurosurgical Procedures,
pubmed-meshheading:11927472-Operating Rooms,
pubmed-meshheading:11927472-Propofol,
pubmed-meshheading:11927472-Staphylococcus epidermidis,
pubmed-meshheading:11927472-Syringes
|
pubmed:year |
2002
|
pubmed:articleTitle |
Routine handling of propofol prevents contamination as effectively as does strict adherence to the manufacturer's recommendations.
|
pubmed:affiliation |
Departments of Anaesthesia and Intensive Care Medicine, Hygiene and Social Medicine, and Pathology, University of Innsbruck, Innsbruck, Austria.
|
pubmed:publicationType |
Journal Article
|